New Patient Recruitment Centres for late-phase clinical research
NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...
NICE recommends new triple negative breast cancer treatment
Draft guidance published today by the National Institute for Health and Care Excellence (NICE) recommends Roche's Tecentriq®▼ (atezolizumab) for treating people with a type...
NIHR plans to resume paused non-COVID-19 health research
The National Institute for Health Research (NIHR) has set out a framework for the resumption of non-COVID-19 health research that has been paused as...
AstraZeneca to supply COVID-19 vaccine from September
AstraZeneca has advanced its response to the global COVID-19 challenge and agreed to supply at least 400 million doses of Oxford’s potential COVID-19 vaccine...
First UK participant enters the largest COVID-19 interventional trial investigating hydroxychloroquine
The first UK participant enters the largest COVID-19 interventional trial in the world investigating hydroxychloroquine and involving 40,000 frontline healthcare workers The first UK frontline...
Patient diversity needed in COVID-19 research
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the...
Moderna announces positive interim data from coronavirus vaccine trial
Moderna, Inc has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by...
Government begins large scale coronavirus immunity study
Up to 20,000 people are being asked to take part in a new government-funded coronavirus immunity study to further track the extent of the...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...
Latest articles
From HIV to COVID-19: Charting the path of patient power
Patient power has evolved considerably since it was born to represent the voiceless during the 1980s HIV/AIDS crisis. Will COVID-19 provide the movement with...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
Popular articles
Strategy, curiosity & solutions to align pharma and the NHS
Mehrnaz Campbell shares her experience of running a UK business from the US developing strategies to align pharma and the NHS. What’s your career background? I...
From HIV to COVID-19: Charting the path of patient power
Patient power has evolved considerably since it was born to represent the voiceless during the 1980s HIV/AIDS crisis. Will COVID-19 provide the movement with...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
It’s all in the mind(set): digital transformation in pharma
The importance of mindset and company culture to enable digital transformation in pharma. Top 5 Takeaways Start with defining and understanding the traditional roadblocks of...